Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Revenue

Betta Pharmaceuticals had revenue of 1.04B CNY in the quarter ending March 31, 2026, with 13.33% growth. This brings the company's revenue in the last twelve months to 3.73B, up 21.40% year-over-year. In the year 2025, Betta Pharmaceuticals had annual revenue of 3.61B with 24.81% growth.

• Revenue (ttm): 3.73B
• Revenue Growth: +21.40%
• P/S Ratio: 5.58
• Revenue / Employee: 2.09M
• Employees: 1,961
• Market Cap: 20.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.61B	717.39M	24.81%
Dec 31, 2024	2.89B	435.75M	17.74%
Dec 31, 2023	2.46B	79.57M	3.35%
Dec 31, 2022	2.38B	130.77M	5.82%
Jan 1, 2022	2.25B	375.59M	20.08%